Evidence map›Paper›PMID 40158695›Full record

ReviewBiological psychiatry. Cognitive neuroscience and neuroimaging2025

Difficult-to-Treat Anxiety: A Neurocomputational Framework.

Martin P Paulus, Murray B Stein

Abstract readReview
In one paragraph

Review in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Martin P PaulusLaureate Institute for Brain Research, University of Tulsa, Tulsa, Oklahoma; Department of Psychiatry, University of California San Diego, La Jolla, California; Oxley College of Health Science, University of Tulsa, Tulsa, Oklahoma. Electronic address: mpaulus@laureateinstitute.org.
Murray B SteinDepartment of Psychiatry, University of California San Diego, La Jolla, California; Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, California; Psychiatry Service, Veterans Affairs San Diego Healthcare System, San Diego, California.

Funding

The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)P20GM121312 · NIGMS · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI MARTIN P. PAULUS · 2017 to 2026
$23.7M
15/21 ABCD-USA Consortium: Research Project Site at LIBRU01DA050989 · NIDA · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI ROBIN L AUPPERLE, MARTIN P. PAULUS · 2020 to 2026
$14.7M
NIDA NIH HHS U01 DA050989NIGMS NIH HHS P20 GM121312
6 · The paper itself

Abstract

Anxiety disorders, affecting approximately 1 in 9 individuals globally, impose significant socioeconomic and health burdens, with many individuals failing to achieve symptom remission despite standard treatments. Difficult-to-treat anxiety (DTA) encompasses a broad spectrum of persistent anxiety disorders that remain refractory to conventional interventions, necessitating a shift from rigid response-based criteria to a mechanistically driven framework that integrates computational psychiatry and systems neuroscience. Dysregulated approach-avoidance decision making, where heightened punishment sensitivity, inflexible belief updating, and uncertainty misestimation drive persistent avoidance behaviors and reinforce maladaptive anxiety cycles, is central to DTA. Computational modeling of reinforcement learning tasks reveals exaggerated Pavlovian biases and impaired exploratory learning, while predictive processing models highlight overestimation of threat and rigidity in safety learning, perpetuating chronic anxiety. Neural dysfunction in default mode and negative affective networks, characterized by hyperstable attractor states in the amygdala and impaired top-down regulation by the prefrontal cortex, further sustains maladaptive anxiety states. Novel interventions that target these dysfunctions-such as neuromodulation, precision pharmacotherapy, and personalized digital therapeutics-offer potential breakthroughs in managing DTA. In this review, we synthesize current evidence on computational, neural, and behavioral mechanisms that underlie DTA and propose an integrative, process-targeted approach to assessment and treatment. Future research must refine biomarker-driven subtyping and individualized interventions, moving beyond trial-and-error approaches toward mechanistically informed precision psychiatry for persistent anxiety disorders.

Indexed as

AnxietyAnxiety DisordersBrainComputer SimulationHumansAnxiety disordersCognitive processesEmotion regulationNeuroscienceTreatment resistance

Identifiers

PMID40158695
PMCPMC12353885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.